Membranous ABCG2 expression in colorectal cancer independently correlates with shortened patient survival

Cancer Biomarkers

Volumn 13, Issue 2, 2013, Pages 81-88

  Wang, Xinying ^a,b   Xia, Bingqing ^a,b   Liang, Yan ^a,b   Peng, Liang ^a,b   Wang, Zhongqiu ^a,b   Zhuo, Jingwei ^a,b   Wang, Weifei ^c   Jiang, Bo ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Guangdong Provincial Key Laboratory of Gastroenterology   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

ABCG2; colorectal cancer; membranous expression; survival

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; PARAFFIN;

ADULT; AGED; APICAL MEMBRANE; ARTICLE; COLORECTAL CANCER; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; SURVIVAL;

ADULT; AGED; ATP-BINDING CASSETTE TRANSPORTERS; CELL MEMBRANE; COLORECTAL NEOPLASMS; CYTOPLASM; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880564682     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130344     Document Type: Article

References (25)

1. P. Zhao, M. Dai, W. Chen, N. Li. Cancer trends in China. Jpn J Clin Oncol 40 (2010) 281-5.
2. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-49.
3. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, A.K. Rishi, D.D. Ross. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95 (1998) 15665-70. (Pubitemid 29018757)
4. I.D. Kerr, A.J. Haider, I.C. Gelissen. The ABCG family of membrane-associated transporters: You don't have to be big to be mighty. Br J Pharmacol 164 (2011) 1767-79.
5. K. Miyake, L. Mickley, T. Litman, Z. Zhan, R. Robey, B. Cristensen, M. Brangi, L. Greenberger, M. Dean, T. Fojo, S.E. Bates. Molecular cloning of cDNAs which are highly overex-pressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res 59 (1999) 8-13. (Pubitemid 29062946)
6. M.M. Gottesman, T. Fojo, S.E. Bates. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat Rev Cancer 2 (2002) 48-58. (Pubitemid 37328807)
7. L.A. Doyle, D.D. Ross. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22 (2003) 7340-58. (Pubitemid 37487163)
8. S.J. Zhou, K.D. Bunting, A.M. Colapietro, J. Sampath, J.J. Morris, I. Lagutina, G.C. Grosveld, M. Osawa, H. Nakauchi, B.P. Sorrentino. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7 (2001) 1028-34. (Pubitemid 32937383)
9. R.D. Krishnamurthy, T. Nakanishi, K. Bailey-Dell, S. Zhou, K.E. Mercer, B. Sarkadi, B.P. Sorrentino, J.D. Schuetz. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279 (2004) 24218-25. (Pubitemid 38725283)
10. Z. Benderra, A.M. Faussat, L. Sayada, J.Y. Perrot, D. Chaoui, J.P. Marie, O. Legrand. Breast cancer resistance protein and Pglycoprotein in 149 adult acute myeloid leukemias. Clin Cancer Res 10 (2004) 7896-902. (Pubitemid 39587528)
11. B. Uggla, E. Stahl, D. Wagsater, C. Paul, M.G. Karlsson, A. Sirsjo, U. Tidefelt. BCRP mRNA expression v. clinical outcome in 40 adult AML patients. Leuk Res 29 (2005) 141-6. (Pubitemid 39647507)
12. A. Suvannasankha, H. Minderman, K.L. O'Loughlin, T. Nakanishi, L.A. Ford, W.R. Greco, M. Wetzler, D.D. Ross, M.R. Baer. Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survival. Br J Haematol 127 (2004) 392-8. (Pubitemid 39536590)
13. K. Yoh, G. Ishii, T. Yokose, Y. Minegishi, K. Tsuta, K. Goto, Y. Nishiwaki, T. Kodama, M. Suga, A. Ochiai. Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer. Clin Cancer Res 10 (2004) 1691-7. (Pubitemid 38435560)
14. Y.H. Kim, G. Ishii, K. Goto, S. Ota, K. Kubota, Y. Murata, M. Mishima, N. Saijo, Y. Nishiwaki, A. Ochiai. Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer. Lung Cancer 65 (2009) 105-11.
15. S. Tsunoda, T. Okumura, T. Ito, K. Kondo, C. Ortiz, E. Tanaka, G. Watanabe, A. Itami, Y. Sakai, Y. Shimada. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma. Oncology 71 (2006) 251-8.
16. N. Gupta, P.M. Martin, S. Miyauchi, S. Ananth, A.V. Herdman, R.G. Martindale, R. Podolsky, V. Ganapathy. Downregulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem Biophys Res Commun 343 (2006) 571-7.
17. H.G. Liu, Y.F. Pan, J. You, O.C. Wang, K.T. Huang, X.H. Zhang. Expression of ABCG2 and its significance in colorectal cancer. Asian Pac J Cancer Prev 11 (2010) 845-8.
18. S.C. Glasgow, J. Yu, L.P. Carvalho, W.D. Shannon, J.W. Fleshman, H.L. McLeod. Unfavourable expression of phar-macologic markers in mucinous colorectal cancer. Br J Cancer 92 (2005) 259-64. (Pubitemid 40343138)
19. T. Ishikawa, H. Saito, H. Hirano, Y. Inoue, Y. Ikegami. Human ABC Transporter ABCG2 in Cancer Chemotherapy: Drug Molecular Design to Circumvent Multidrug Resistance. Methods Mol Biol 910 (2012) 267-78.
20. Y. Xie, K. Xu, D.E. Linn, X. Yang, Z. Guo, H. Shimelis, T. Nakanishi, D.D. Ross, H. Chen, L. Fazli, M.E. Gleave, Y. Qiu. The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem 283 (2008) 3349-56.
21. M. Mogi, J. Yang, J.F. Lambert, G.A. Colvin, I. Shiojima, C. Skurk, R. Summer, A. Fine, P.J. Quesenberry, K. Walsh. Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem 278 (2003) 39068-75. (Pubitemid 37221810)
22. A.M. Bleau, D. Hambardzumyan, T. Ozawa, E.I. Fomchenko, J.T. Huse, C.W. Brennan, E.C. Holland. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4 (2009) 226-35.
23. T. Winder, H.J. Lenz. Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. Gastroenterology 138 (2010) 2163-76.
24. Z.U. Meyer, H.E. Schwabedissen, M. Grube, A. Dreisbach, G. Jedlitschky, K. Meissner, K. Linnemann, C. Fusch, C.A. Ritter, U. Volker, H.K. Kroemer. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 34 (2006) 524-33.
25. J.J. Deuring, C. de Haar, C.L. Koelewijn, E.J. Kuipers, M.P. Peppelenbosch, C.J. van der Woude. Absence of ABCG2-mediated mucosal detoxification in patients with active inflammatory bowel disease is due to impeded protein folding. Biochem J 441 (2012) 87-93.